The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Although Bayer’s top-selling drug Xarelto lost market exclusivity in ... exec says Oelrich argued elinzanetant’s mechanism of action could help it differentiate itself. While Veozah is a ...

Conclusions: The ARCADIA trial hypothesis is that recurrent CS in randomized patients could be reduced by apixaban over aspirin, as the stroke mechanism is hypothesized to be like that in atrial ...

Operator Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings conference call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference ...

Medications included apixaban, deferasirox ... and endothelial dysfunction is another hypothesized pathophysiological mechanism of PRES. These laboratory findings, combined with the MRI findings ...

Finally, XARELTO sales growth was driven by favorable ... We see each of these molecules that we're developing, having unique mechanisms that can play in different subpopulations.

Furthermore, understanding the mechanisms behind APS has been a focus ... A study comparing apixaban, a newer anticoagulant, with warfarin, the traditional treatment, indicated that apixaban ...

Asundexian is viewed as a successor to the company’s Johnson & Johnson-partnered anticoagulant Factor Xa inhibitor Xarelto (rivaroxaban), its biggest-selling drug, which contributed €3.3 ...

BMS is a longstanding player in cardiovascular with drugs like Pfizer-partnered Eliquis (apixaban ... which are both based on novel mechanisms of action – have been keenly anticipated by ...